Expanding Erythema With Facial Weakness

An adult who hiked in wooded northeastern terrain develops an expanding oval erythematous lesion on the thigh, then one week later notices inability to close the left eye and weakness of the entire left face. There is mild headache but no neck stiffness, limb weakness, chest pain, palpitations, or syncope. The forehead is involved, supporting a peripheral seventh nerve palsy. A compatible erythema migrans lesion plus facial palsy suggests early disseminated Lyme disease even though no tick was noticed.

Case focus#

The central decision is whether the skin lesion is clinically typical erythema migrans and whether facial palsy is isolated or accompanied by meningitis, radiculoneuritis, carditis, or another neurologic cause. Typical erythema migrans is diagnosed clinically, while serology is useful for disseminated manifestations but can be negative early. Lumbar puncture and intravenous therapy depend on the neurologic syndrome, not facial weakness alone.

This analysis concentrates on the opening phase: building a usable problem representation, recognizing time-sensitive threats, and choosing the safest next action before diagnostic certainty is available.

Problem representation#

The useful representation is not a label alone. It combines the tempo of the problem, the setting, the physiologic or functional threat, the evidence already available, and the important information that is still missing. For this lyme disease with facial nerve palsy analysis, the working frame must remain broad enough to compare Early disseminated Lyme neuroborreliosis, Idiopathic facial palsy, Central facial weakness from stroke, Herpes zoster oticus without allowing a familiar first impression to become an untested conclusion.

The setting materially changes the plan: An urgent clinic near a Lyme endemic region with neurologic examination, electrocardiography, serology, lumbar puncture access, and prompt antimicrobial treatment.. Available monitoring, access to consultation, travel time, record continuity, and the reliability of follow-through alter what counts as a safe next step. A plan that is reasonable in a continuously monitored environment may be unsafe when results return after discharge or urgent reassessment is difficult.

Immediate safety priorities#

• Cardiac involvement: Syncope, presyncope, palpitations, chest pain, dyspnea, or marked PR prolongation can indicate Lyme carditis and requires urgent monitoring.
• Meningitis or encephalitis: Severe headache, neck stiffness, photophobia, fever, altered cognition, or persistent vomiting requires urgent central nervous system evaluation.
• Broader neurologic deficit: Limb weakness, severe radicular pain, ataxia, multiple cranial neuropathies, or sphincter symptoms suggests more extensive neuroborreliosis or another lesion.
• Eye exposure injury: Pain, redness, photophobia, or reduced vision with incomplete eyelid closure can signal corneal injury requiring prompt eye assessment.

These findings are action signals rather than diagnostic shortcuts. They determine the pace of stabilization, consultation, and escalation while the causal analysis continues in parallel.

Prioritized differential diagnosis#

Early disseminated Lyme neuroborreliosis#

What supports it. Expanding erythema migrans, endemic exposure, and acute peripheral facial palsy form a strongly compatible disseminated pattern.

What argues against it or keeps uncertainty open. An incompatible geography, nonexpanding lesion, isolated central facial weakness, or a confirmed alternative lowers probability.

Discriminating next step. Treat the compatible syndrome, obtain recommended two tier serology for disseminated disease, and assess for meningitic, radicular, and cardiac involvement.

Idiopathic facial palsy#

What supports it. Acute isolated unilateral peripheral seventh nerve weakness without systemic, skin, or other neurologic findings is common.

What argues against it or keeps uncertainty open. A concurrent compatible erythema migrans lesion and tick exposure strongly favors Lyme associated palsy.

Discriminating next step. Examine skin and neurologic function completely, assess Lyme epidemiology, and use evidence based corticosteroid and antiviral decisions only after the context is defined.

Central facial weakness from stroke#

What supports it. Forehead sparing, limb weakness, aphasia, gaze deviation, ataxia, or abrupt broader neurologic loss supports a central lesion.

What argues against it or keeps uncertainty open. Weakness of the forehead and lower face without other focal deficits supports a peripheral nerve process.

Discriminating next step. Activate stroke evaluation immediately when central signs or uncertain localization are present.

Herpes zoster oticus#

What supports it. Severe ear pain, vesicles in the canal or palate, hearing loss, vertigo, and peripheral facial weakness support Ramsay Hunt syndrome.

What argues against it or keeps uncertainty open. Expanding thigh erythema without ear vesicles or vestibular symptoms makes zoster less likely.

Discriminating next step. Inspect ear canal and palate, test hearing and vestibular function, and start time sensitive antiviral and corticosteroid care when appropriate.

Cellulitis or arthropod reaction#

What supports it. Tender warmth, edema, acute pain, pruritus, a punctum, and rapid local response can suggest bacterial cellulitis or bite reaction.

What argues against it or keeps uncertainty open. Steady centrifugal expansion with minimal pain and later facial palsy fits erythema migrans more closely.

Discriminating next step. Use lesion evolution, exposure, systemic findings, and serial photographs rather than requiring a bullseye morphology.

The differential is ranked but not closed. Probability, consequence of delay, reversibility, and test burden are considered together. A dangerous alternative can deserve early exclusion even when it is not the statistically most likely explanation.

Evidence-gathering strategy#

• Peripheral versus central facial localization. Forehead movement, eye closure, lower facial strength, limb examination, speech, coordination, and gait distinguish nerve palsy from stroke. Interpretation: Any central sign triggers emergency neuroimaging and stroke care before an infectious explanation is accepted.
• Skin and exposure assessment. Lesion expansion, size, symptoms, location, endemic geography, outdoor activity, animals, and prior photographs establish erythema migrans probability. Interpretation: A typical lesion in a credible exposure setting is a clinical diagnosis and should not wait for serology.
• Two tier Lyme serology. Antibody testing supports disseminated neurologic disease when performed and interpreted according to validated algorithms. Interpretation: Early negative testing may require convalescent reassessment if suspicion remains, while isolated bands or unvalidated panels should not drive diagnosis.
• Meningitic and radicular assessment. Headache, neck stiffness, photophobia, radicular pain, multiple neuropathies, and cognitive change determine need for lumbar puncture or broader imaging. Interpretation: Cerebrospinal fluid is reserved for syndromes where it changes diagnosis or route and duration of treatment.
• Cardiac screening from symptoms and ECG. Syncope, palpitations, dyspnea, chest pain, bradycardia, and PR interval can reveal carditis accompanying disseminated infection. Interpretation: Symptoms or conduction delay require monitoring and treatment escalation; routine admission is not needed for every isolated facial palsy.

Tests are selected because they can change a decision, not because a broad panel feels comprehensive. Results are interpreted with their timing, pretest probability, measurement limitations, recent treatment, and the possibility that an apparently reassuring value was obtained too early or under the wrong conditions.

Progressive course and interpretation#

A full neurologic examination shows isolated peripheral facial weakness and no meningeal signs. Electrocardiography has a normal PR interval and rhythm. Two tier serology is sent because disseminated neurologic involvement is suspected, and treatment is begun without waiting for the result. Eye protection starts immediately because eyelid closure is incomplete. Headache resolves, the rash fades, and facial function begins to recover. New palpitations or worsening headache would have triggered repeat cardiac or cerebrospinal assessment.

The trajectory is evidence. Improvement after an intervention may support a mechanism without proving it, while nonresponse should prompt a check of the diagnosis, delivery of the intervention, timing, adherence, and competing pathology. Discordant data should be explained rather than averaged away.

Management reasoning#

• Begin appropriate antimicrobial treatment. Agent, route, and duration follow the neurologic manifestation, age, pregnancy, allergy, and ability to absorb oral therapy.
• Protect the cornea. Lubrication, nighttime eyelid closure, and prompt eye review for symptoms prevent exposure keratopathy during facial weakness.
• Monitor for disseminated complications. New cardiac, meningeal, radicular, joint, or additional cranial nerve findings should change testing, route, and disposition.
• Use corticosteroids carefully. Evidence is uncertain for corticosteroids in established Lyme associated facial palsy, so avoid assuming idiopathic palsy evidence transfers directly.
• Set recovery expectations. Facial function may recover over weeks, and persistent weakness requires reassessment of diagnosis, eye protection, and rehabilitation needs.

Management remains proportional to severity and uncertainty. It includes explicit monitoring targets, foreseeable adverse effects, and stop or escalation conditions. Exact drug selection, dosing, and procedure details depend on verified individual factors, current local protocols, contraindications, and the responsible treating team; the analytical value here is the decision structure and its guardrails.

Communication and shared decisions#

Explain that many people do not recall a tick bite and that erythema migrans usually expands but does not need a classic bullseye appearance. Review why early tests can be negative, why repeated unvalidated testing is not useful, and why eye lubrication and closure protection matter while the nerve recovers. Discuss the uncertainty around adding corticosteroids specifically when Lyme associated facial palsy is established.

The communication task includes what is known, what remains uncertain, why the next step is recommended, what alternatives exist, and which change should trigger urgent reassessment. Teach-back, qualified interpretation when needed, accessible formats, and a named owner for pending results turn information into a safer plan.

Continuity and safety net#

• Seek emergency care for fainting, palpitations, chest pain, shortness of breath, severe headache, neck stiffness, confusion, or new limb weakness.
• Obtain prompt eye care for pain, redness, light sensitivity, foreign body sensation, or reduced vision while eyelid closure is incomplete.
• Complete the prescribed antimicrobial course and return if the rash expands during treatment or new neurologic, cardiac, or joint symptoms appear.
• Ensure serology and any ECG or cerebrospinal results are reviewed by a named clinician rather than released without interpretation.

Follow-through is verified, not assumed. The record should identify who receives each pending result, the time window for reassessment, the contingency if contact fails, and the clinical or functional outcome that will show whether the plan is working.

Equity and systems analysis#

Outdoor workers, people with unstable housing, and rural residents may have high exposure and delayed access, while darker skin can make erythema less visually obvious. Ask about texture, expansion, warmth, and symptom evolution rather than relying on bright redness. Arrange treatment and follow-up that are feasible without repeated long travel, and use qualified interpretation for neurologic instructions.

Access conditions belong in the causal model. Transportation, medication cost, work schedules, caregiving, health literacy, language, disability access, digital connectivity, and prior experiences of care can alter both the observed presentation and the feasibility of the plan. Addressing those constraints improves diagnostic validity as well as fairness.

Reasoning capabilities demonstrated#

• Recognizes erythema migrans without requiring a bullseye or remembered tick bite.
• Localizes peripheral facial palsy while maintaining an emergency pathway for stroke signs.
• Uses clinical diagnosis for typical erythema migrans and validated serology for disseminated disease.
• Screens facial palsy for meningitic, radicular, cardiac, and ocular complications.
• Explains corticosteroid uncertainty without delaying antibiotic or corneal protection.

Key takeaways#

• An expanding lesion plus peripheral facial weakness in an endemic exposure setting strongly suggests early disseminated Lyme disease.
• Typical erythema migrans is diagnosed clinically, and early serology can be negative.
• Eye protection and screening for carditis or broader neurologic involvement are immediate parts of care.